STERIS plc Operating Cash Flow
STERIS plc (STE) reported Operating Cash Flow of $367.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07
- STERIS plc net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $367.10M, a 12.60% decline year-over-year.
- STERIS plc net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $335.40M, a 28.60% increase year-over-year.
- STERIS plc net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $298.20M, a 10.40% decline year-over-year.
- STERIS plc net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $287.80M, a 14.75% increase year-over-year.
- STERIS plc net cash provided by (used in) operating activities for fiscal 2026 was $1.34B, a 16.84% increase from fiscal 2025.
- STERIS plc net cash provided by (used in) operating activities for fiscal 2025 was $1.15B, a 17.96% increase from fiscal 2024.
- STERIS plc net cash provided by (used in) operating activities for fiscal 2024 was $973.30M, a 28.58% increase from fiscal 2023.
- STERIS plc net cash provided by (used in) operating activities for fiscal 2023 was $756.95M, a 10.53% increase from fiscal 2022.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $367.10M 10-Q · filed 2026-08-07 | $702.50M derived: sum of 2 quarters · filed 2026-08-07 | $1.00B derived: sum of 3 quarters · filed 2026-08-07 | $1.29B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $335.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $633.60M derived: sum of 2 quarters · filed 2026-05-29 | $921.40M derived: sum of 3 quarters · filed 2026-05-29 | $1.34B 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | $298.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $586.00M derived: sum of 2 quarters · filed 2026-02-06 | $1.01B 10-Q · filed 2026-02-06 | $1.27B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-09-30 | $287.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $707.80M 10-Q · filed 2025-11-06 | $968.60M derived: sum of 3 quarters · filed 2026-08-07 | $1.30B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $420.00M 10-Q · filed 2026-08-07 | $680.80M derived: sum of 2 quarters · filed 2026-08-07 | $1.01B derived: sum of 3 quarters · filed 2026-08-07 | $1.26B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $260.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $593.60M derived: sum of 2 quarters · filed 2026-05-29 | $844.40M derived: sum of 3 quarters · filed 2026-05-29 | $1.15B 10-K · filed 2026-05-29 | $1.15B 10-K · filed 2025-05-29 | |||
| 2024-12-31 | $332.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $583.60M derived: sum of 2 quarters · filed 2026-02-06 | $887.30M 10-Q · filed 2026-02-06 | $887.31M 10-Q · filed 2025-02-07 | $1.14B derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-09-30 | $250.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $554.50M 10-Q · filed 2025-11-06 | $554.47M 10-Q · filed 2024-11-07 | $809.33M derived: sum of 3 quarters · filed 2026-05-29 | $1.10B derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-06-30 | $303.70M 10-Q · filed 2025-08-07 | $303.74M 10-Q · filed 2024-08-08 | $558.53M derived: sum of 2 quarters · filed 2026-05-29 | $849.78M derived: sum of 3 quarters · filed 2026-05-29 | $995.87M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-03-31 | $254.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $546.08M derived: sum of 2 quarters · filed 2026-05-29 | $692.17M derived: sum of 3 quarters · filed 2026-05-29 | $973.30M 10-K · filed 2026-05-29 | $973.27M 10-K · filed 2024-05-29 | |||
| 2023-12-31 | $291.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07 | $437.34M derived: sum of 2 quarters · filed 2025-02-07 | $718.47M 10-Q · filed 2025-02-07 | $934.27M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-09-30 | $146.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $427.22M 10-Q · filed 2024-11-07 | $643.02M derived: sum of 3 quarters · filed 2025-05-29 | $848.60M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-06-30 | $281.13M 10-Q · filed 2024-08-08 | $496.93M derived: sum of 2 quarters · filed 2025-05-29 | $702.51M derived: sum of 3 quarters · filed 2025-05-29 | $806.33M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-03-31 | $215.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $421.38M derived: sum of 2 quarters · filed 2025-05-29 | $525.20M derived: sum of 3 quarters · filed 2025-05-29 | $756.95M 10-K · filed 2025-05-29 | ||||
| 2022-12-31 | $205.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $309.40M derived: sum of 2 quarters · filed 2024-02-08 | $541.15M 10-Q · filed 2024-02-08 | $712.88M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-09-30 | $103.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-07 | $335.57M 10-Q · filed 2023-11-07 | $507.30M derived: sum of 3 quarters · filed 2024-05-29 | $751.62M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-06-30 | $231.75M 10-Q · filed 2023-08-08 | $403.48M derived: sum of 2 quarters · filed 2024-05-29 | $647.79M derived: sum of 3 quarters · filed 2024-05-29 | $819.13M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-03-31 | $171.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $416.05M derived: sum of 2 quarters · filed 2024-05-29 | $587.38M derived: sum of 3 quarters · filed 2024-05-29 | $684.81M 10-K · filed 2024-05-29 | ||||
| 2021-12-31 | $244.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-08 | $415.65M derived: sum of 2 quarters · filed 2023-02-08 | $513.08M 10-Q · filed 2023-02-08 | $700.93M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-09-30 | $171.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | $268.77M 10-Q · filed 2022-11-09 | $456.62M derived: sum of 3 quarters · filed 2023-05-26 | $662.33M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-06-30 | $97.43M 10-Q · filed 2022-08-08 | $285.28M derived: sum of 2 quarters · filed 2023-05-26 | $490.99M derived: sum of 3 quarters · filed 2023-05-26 | $652.94M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-03-31 | $187.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $393.57M derived: sum of 2 quarters · filed 2023-05-26 | $555.52M derived: sum of 3 quarters · filed 2023-05-26 | $689.64M 10-K · filed 2023-05-26 | ||||
| 2020-12-31 | $205.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09 | $367.66M derived: sum of 2 quarters · filed 2022-02-09 | $501.79M 10-Q · filed 2022-02-09 | $701.02M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-09-30 | $161.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08 | $296.07M 10-Q · filed 2021-11-08 | $495.31M derived: sum of 3 quarters · filed 2022-05-31 | $626.63M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-06-30 | $134.12M 10-Q · filed 2021-08-09 | $333.36M derived: sum of 2 quarters · filed 2022-05-31 | $464.68M derived: sum of 3 quarters · filed 2022-05-31 | $615.34M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-03-31 | $199.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | $330.56M derived: sum of 2 quarters · filed 2022-05-31 | $481.22M derived: sum of 3 quarters · filed 2022-05-31 | $590.56M 10-K · filed 2022-05-31 | ||||
| 2019-12-31 | $131.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09 | $281.99M derived: sum of 2 quarters · filed 2021-02-09 | $391.33M 10-Q · filed 2021-02-09 | $570.25M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-09-30 | $150.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-06 | $260.00M 10-Q · filed 2020-11-06 | $438.93M derived: sum of 3 quarters · filed 2021-05-28 | $572.80M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-06-30 | $109.34M 10-Q · filed 2020-08-07 | $288.26M derived: sum of 2 quarters · filed 2021-05-28 | $422.14M derived: sum of 3 quarters · filed 2021-05-28 | $548.06M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-03-31 | $178.93M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | $312.80M derived: sum of 2 quarters · filed 2021-05-28 | $438.73M derived: sum of 3 quarters · filed 2021-05-28 | $539.50M 10-K · filed 2021-05-28 | ||||
| 2018-12-31 | $133.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $259.80M derived: sum of 2 quarters · filed 2020-02-10 | $360.58M 10-Q · filed 2020-02-10 | |||||
| 2018-09-30 | $125.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $226.70M 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | $100.78M 10-Q · filed 2019-08-07 | |||||||
| 2018-03-31 | $457.63M 8-K · filed 2021-02-09 | |||||||
| 2017-03-31 | $424.09M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |